Curi Bio Unlocks Advanced Cardiac Insights with Novoheart Integration
Saved in:
| Title: | Curi Bio Unlocks Advanced Cardiac Insights with Novoheart Integration |
|---|---|
| Authors: | Curi Bio |
| Source: | Business Wire (English). 12/19/2024. |
| Abstract: | Curi Bio, the industry leader in delivering human functional data to the drug discovery community, and Novoheart, maker of the industry’s most sophisticated and comprehensive human cardiac tissue engineering platforms, today announced the integration of Novoheart’s MyHeart™ human ventricular cardiac organoid chamber (hvCoC) platform, also known as the “Human Heart-in-a-Jar,” into Curi Bio’s proprietary cloud-based Pulse™ analysis platform. Through this collaboration and joint commercialization, this advancement enables users of Novoheart’s advanced hvCoC to analyze their data directly into Curi Bio’s Pulse analytics platform, providing biopharmaceutical researchers with deeper, actionable insights into cardiac drug development and disease modeling. [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Curi Bio, the industry leader in delivering human functional data to the drug discovery community, and Novoheart, maker of the industry’s most sophisticated and comprehensive human cardiac tissue engineering platforms, today announced the integration of Novoheart’s MyHeart™ human ventricular cardiac organoid chamber (hvCoC) platform, also known as the “Human Heart-in-a-Jar,” into Curi Bio’s proprietary cloud-based Pulse™ analysis platform. Through this collaboration and joint commercialization, this advancement enables users of Novoheart’s advanced hvCoC to analyze their data directly into Curi Bio’s Pulse analytics platform, providing biopharmaceutical researchers with deeper, actionable insights into cardiac drug development and disease modeling. [ABSTRACT FROM PUBLISHER] |
|---|
